The Challenges of LC–MS/MS Analysis of Opiates and Opioids in Urine
- 21 November 2013
- journal article
- review article
- Published by Taylor & Francis in Bioanalysis
- Vol. 5 (22) , 2803-2820
Abstract
Opioids are some of the most commonly prescribed and abused drugs around the world. Primarily used for anesthesia or pain management, other opioids can also be used in the treatment of opioid addiction. Given these facts, clinicians often randomly test or monitor their patients to determine compliance or abstinence from these drugs via immunoassay methods. When a positive screen is obtained, a confirmatory assay is carried out and although the gold standard has been GC-MS, LC-MS/MS is fast becoming a valid and popular alternative. This review will discuss opioids, the complex metabolic pathways, the measurement of these drugs, the challenges involved and, finally, will describe some LC-MS/MS methods published from 2003 until 2013.Keywords
This publication has 71 references indexed in Scilit:
- Improved Detection of Opioid Use in Chronic Pain Patients through Monitoring of Opioid Glucuronides in UrineJournal of Analytical Toxicology, 2012
- A high‐throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC–MS/MSJournal of Mass Spectrometry, 2008
- Association of Personality Disorders, Family Conflicts and Treatment with Quality of Life in Opiate AddictionEuropean Addiction Research, 2008
- Validation of direct injection electrospray LC‐MS/MS for confirmation of opiates in urine drug testingJournal of Mass Spectrometry, 2007
- Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.Experimental and Clinical Psychopharmacology, 2005
- Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography–tandem mass spectrometry with respect to criteria for compound identificationJournal of Chromatography B, 2004
- Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor geneNature, 1996
- Comparative metabolism of codeine in man, rat, dog, guinea-pig and rabbit: identification of four new metabolitesJournal of Pharmacy and Pharmacology, 1979
- Isolation and Identification of Morphine 3- and 6-Glucuronides, Morphine 3,6-Diglucuronide, Morphine 3-Ethereal Sulfate, Normorphine, and Normorphine 6-Glucuronide as Morphine Metabolites in HumansJournal of Pharmaceutical Sciences, 1977
- Actions and Metabolism of Codeine (Methylmorphine) Administration by Continuous Intravenous Infusion to HumansClinical Toxicology, 1977